• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.16% Nasdaq Up0.25%

    More On LUPIN.NS



    News & Info


    Analyst Coverage


    • Major Holders
    • Insider Transactions
    • Insider Roster


    Lupin Limited (LUPIN.NS)

    1,800.75 Up 8.70(0.49%) 5:59AM EDT
    Add to Portfolio
    ProfileGet Profile for:
    Lupin Limited
    Laxmi Towers, B Wing
    Bandra Kurla Complex
    Mumbai, 400051
    India - Map
    Phone: 91 22 6640 2222
    Fax: 91 22 6640 2130
    Website: http://www.lupinworld.com

    Index Membership:N/A
    Industry:Drugs - Generic
    Full Time Employees:N/A

    Business Summary 

    Lupin Limited, a pharmaceutical company, produces, develops, and markets a range of branded and generic formulations and active pharmaceutical ingredients (APIs) primarily in India, the United States, and Japan. It offers various formulations for use in the areas of cephalosporin, cardiovascular (CVS), central nervous system (CNS), anti-asthma, anti-tuberculosis, diabetology, dermatology, gastro intestinal, and other therapy segments; and APIs for use in therapeutic areas of antibiotics, anti-tuberculosis, CVS, CNS, analgesics, and anti-gout. The company also develops and out-licenses its drug delivery technologies and platforms; and creates and develops biosimilars for various therapeutic indications, such as oncology, inflammation, antivirals, osteoporosis, and rheumatoid arthritis. In addition, it is engaged in the novel drug discovery and development programs for use in the treatment of metabolic disorders, pain and inflammation, autoimmune diseases, CNS disorders, cancer, and infectious diseases. Lupin Limited has strategic development and licensing agreement with Celon Pharma S.A. to develop fluticasone/salmeterol dry powder inhaler product that is a generic version of GlaxoSmithKline’s Advair Diskus; and strategic partnership with Merck Serono S.A. The company was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001 as a result of its amalgamation with Lupin Laboratories Limited. Lupin Limited was founded in 1968 and is headquartered in Mumbai, India.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Lupin Limited

    Key Executives 
    Dr. Desh Bandhu Gupta ,
    Founder, Chairman, Member of Share Transfer Committee and Member of Allotment Committee
    Mrs. Vinita Gupta , 47
    Chief Exec. Officer and Exec. Director
    Mrs. Manju D. Gupta , 71
    Exec. Director, Member of Share Transfer Committee and Member of Allotment Committee
    Mr. Nilesh D. Gupta ,
    Managing Director and Exec. Director
    Mr. Ramesh Swaminathan ,
    Chief Financial Officer
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in INR.